Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis (SURPASS): ClinicalTrials.gov Description === Corporate press release ===
News about our knowledge of the brain and behavior
from Anthony Risser, Ph.D.
News about our knowledge of the brain and behavior
from Anthony Risser, Ph.D.